Mizoribine as an alternative to azathioprine in triple-therapy immunosuppressant regimens in cadaveric renal transplantation.
Lee
H A
HA
Renal Unit, St Mary's Hospital, Portsmouth, England, UK.
Slapak
M
M
Venkatraman
G
G
Mason
J
J
Digard
N
N
Wise
M
M
D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D012263:Ribonucleosides / Q000627:therapeutic use*; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D014527:Uric Acid; C010052:mizoribine; D014508:Urea; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001379:Azathioprine; D001663:Bilirubin